TNFSF12

Protein-coding gene in the species Homo sapiens

TNFSF12

Available structures

PDB

Ortholog search: PDBe RCSB

List of PDB id codes
4HT1

Identifiers

Aliases

TNFSF12, APO3L, DR3LG, TWEAK, TNLG4A, tumor necrosis factor superfamily member 12, TNF superfamily member 12

External IDs

OMIM: 602695; MGI: 1196259; HomoloGene: 7979; GeneCards: TNFSF12; OMA:TNFSF12 - orthologs

Gene location (Human)

Chr.	Chromosome 17 (human)^[1]

Band	17p13.1	Start	7,549,058 bp^[1]
Band	17p13.1	End	7,557,890 bp^[1]

Gene location (Mouse)

Chr.	Chromosome 11 (mouse)^[2]

Band	11\|11 B3	Start	69,577,076 bp^[2]
Band	11\|11 B3	End	69,586,675 bp^[2]

RNA expression pattern

Bgee

Human

Mouse (ortholog)

Top expressed in

right coronary artery

thoracic aorta

ascending aorta

Descending thoracic aorta

left coronary artery

popliteal artery

tibial arteries

gastric mucosa

muscle layer of sigmoid colon

apex of heart

Top expressed in

neural layer of retina

tunica media of zone of aorta

ankle

right lung

ascending aorta

stroma of bone marrow

aortic valve

lactiferous gland

muscle of thigh

More reference expression data

BioGPS

n/a

Gene ontology
Molecular function	cytokine activity protein binding tumor necrosis factor receptor binding signaling receptor binding
Cellular component	integral component of membrane membrane plasma membrane integral component of plasma membrane extracellular region perinuclear region of cytoplasm extracellular space
Biological process	cell differentiation positive regulation of endothelial cell proliferation positive regulation of protein catabolic process extrinsic apoptotic signaling pathway tumor necrosis factor-mediated signaling pathway positive regulation of angiogenesis multicellular organism development angiogenesis immune response apoptotic signaling pathway positive regulation of extrinsic apoptotic signaling pathway endothelial cell migration signal transduction apoptotic process regulation of signaling receptor activity
Sources:Amigo / QuickGO

Orthologs

Species

Human

Mouse

Entrez


8742


21944

Ensembl


ENSG00000239697


ENSMUSG00000097328

UniProt


O43508


O54907

RefSeq (mRNA)


NM_003809


NM_011614

RefSeq (protein)


NP_003800


NP_035744

Location (UCSC)

Chr 17: 7.55 – 7.56 Mb

Chr 11: 69.58 – 69.59 Mb

PubMed search

^[3]

^[4]

Wikidata

View/Edit Human

View/Edit Mouse

Tumor necrosis factor ligand superfamily member 12 also known as TNF-related weak inducer of apoptosis (TWEAK) is a protein that in humans is encoded by the TNFSF12 gene.^[5]^[6]^[7]

Function

TWEAK was discovered in 1997.^[5] The protein encoded by this gene is a cytokine that belongs to the tumor necrosis factor (TNF) ligand family. This protein is a ligand for the FN14/TWEAKR receptor. This cytokine has overlapping signaling functions with TNF, but displays a much wider tissue distribution. Leukocytes are the main source of TWEAK including human resting and activated monocytes, dendritic cells and natural killer cells.^[8] TWEAK can induce apoptosis via multiple pathways of cell death in a cell type-specific manner. This cytokine is also found to promote proliferation and migration of endothelial cells, and thus acts as a regulator of angiogenesis.^[7]

Clinical significance

Excessive activation of the TWEAK pathway in chronic injury has been described to promote pathological tissue changes including chronic inflammation, fibrosis and angiogenesis.^[9] In chronic liver disease, for example, TWEAK expression is enhanced and causes hepatic stellate cells, which are key regulators of liver fibrosis, to proliferate.^[10]

References

^ ^a ^b ^c GRCh38: Ensembl release 89: ENSG00000239697 – Ensembl, May 2017
^ ^a ^b ^c GRCm38: Ensembl release 89: ENSMUSG00000097328 – Ensembl, May 2017
^ "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
^ "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
^ ^a ^b Chicheportiche Y, Bourdon PR, Xu H, Hsu YM, Scott H, Hession C, Garcia I, Browning JL (December 1997). "TWEAK, a new secreted ligand in the tumor necrosis factor family that weakly induces apoptosis". The Journal of Biological Chemistry. 272 (51): 32401–10. doi:10.1074/jbc.272.51.32401. PMID 9405449.
^ Marsters SA, Sheridan JP, Pitti RM, Brush J, Goddard A, Ashkenazi A (April 1998). "Identification of a ligand for the death-domain-containing receptor Apo3". Current Biology. 8 (9): 525–8. Bibcode:1998CBio....8..525M. doi:10.1016/S0960-9822(98)70204-0. PMID 9560343. S2CID 14953579.
^ ^a ^b "Entrez Gene: TNFSF12 tumor necrosis factor (ligand) superfamily, member 12".
^ Maecker H, Varfolomeev E, Kischkel F, Lawrence D, LeBlanc H, Lee W, Hurst S, Danilenko D, Li J, Filvaroff E, Yang B, Daniel D, Ashkenazi A (December 2005). "TWEAK attenuates the transition from innate to adaptive immunity". Cell. 123 (5): 931–44. doi:10.1016/j.cell.2005.09.022. PMID 16325585. S2CID 2660454.
^ Burkly LC (June 2014). "TWEAK/Fn14 axis: the current paradigm of tissue injury-inducible function in the midst of complexities". Seminars in Immunology. The TNF family - challenges ahead. 26 (3): 229–36. doi:10.1016/j.smim.2014.02.006. PMID 24636536.
^ Wilhelm A, Shepherd EL, Amatucci A, Munir M, Reynolds G, Humphreys E, Resheq Y, Adams DH, Hübscher S, Burkly LC, Weston CJ, Afford SC (February 2016). "Interaction of TWEAK with Fn14 leads to the progression of fibrotic liver disease by directly modulating hepatic stellate cell proliferation". The Journal of Pathology. 239 (1): 109–21. doi:10.1002/path.4707. PMC 4949530. PMID 26924336.

Wiley SR, Winkles JA (2004). "TWEAK, a member of the TNF superfamily, is a multifunctional cytokine that binds the TweakR/Fn14 receptor". Cytokine & Growth Factor Reviews. 14 (3–4): 241–9. doi:10.1016/S1359-6101(03)00019-4. PMID 12787562.
Campbell S, Michaelson J, Burkly L, Putterman C (September 2004). "The role of TWEAK/Fn14 in the pathogenesis of inflammation and systemic autoimmunity". Frontiers in Bioscience. 9 (1–3): 2273–84. doi:10.2741/1395. PMID 15353286.
Lynch CN, Wang YC, Lund JK, Chen YW, Leal JA, Wiley SR (March 1999). "TWEAK induces angiogenesis and proliferation of endothelial cells". The Journal of Biological Chemistry. 274 (13): 8455–9. doi:10.1074/jbc.274.13.8455. PMID 10085077.
Kaplan MJ, Ray D, Mo RR, Yung RL, Richardson BC (March 2000). "TRAIL (Apo2 ligand) and TWEAK (Apo3 ligand) mediate CD4+ T cell killing of antigen-presenting macrophages". Journal of Immunology. 164 (6): 2897–904. doi:10.4049/jimmunol.164.6.2897. PMID 10706675.
Kaptein A, Jansen M, Dilaver G, Kitson J, Dash L, Wang E, Owen MJ, Bodmer JL, Tschopp J, Farrow SN (November 2000). "Studies on the interaction between TWEAK and the death receptor WSL-1/TRAMP (DR3)". FEBS Letters. 485 (2–3): 135–41. Bibcode:2000FEBSL.485..135K. doi:10.1016/S0014-5793(00)02219-5. PMID 11094155. S2CID 38403545.
Wiley SR, Cassiano L, Lofton T, Davis-Smith T, Winkles JA, Lindner V, Liu H, Daniel TO, Smith CA, Fanslow WC (November 2001). "A novel TNF receptor family member binds TWEAK and is implicated in angiogenesis". Immunity. 15 (5): 837–46. doi:10.1016/S1074-7613(01)00232-1. PMID 11728344.
Nakayama M, Ishidoh K, Kayagaki N, Kojima Y, Yamaguchi N, Nakano H, Kominami E, Okumura K, Yagita H (January 2002). "Multiple pathways of TWEAK-induced cell death". Journal of Immunology. 168 (2): 734–43. doi:10.4049/jimmunol.168.2.734. PMID 11777967.
Jakubowski A, Browning B, Lukashev M, Sizing I, Thompson JS, Benjamin CD, Hsu YM, Ambrose C, Zheng TS, Burkly LC (January 2002). "Dual role for TWEAK in angiogenic regulation". Journal of Cell Science. 115 (Pt 2): 267–74. doi:10.1242/jcs.115.2.267. PMID 11839778.
Kaplan MJ, Lewis EE, Shelden EA, Somers E, Pavlic R, McCune WJ, Richardson BC (November 2002). "The apoptotic ligands TRAIL, TWEAK, and Fas ligand mediate monocyte death induced by autologous lupus T cells". Journal of Immunology. 169 (10): 6020–9. doi:10.4049/jimmunol.169.10.6020. PMID 12421989.
Harada N, Nakayama M, Nakano H, Fukuchi Y, Yagita H, Okumura K (December 2002). "Pro-inflammatory effect of TWEAK/Fn14 interaction on human umbilical vein endothelial cells". Biochemical and Biophysical Research Communications. 299 (3): 488–93. doi:10.1016/S0006-291X(02)02670-0. PMID 12445828.
Nakayama M, Ishidoh K, Kojima Y, Harada N, Kominami E, Okumura K, Yagita H (January 2003). "Fibroblast growth factor-inducible 14 mediates multiple pathways of TWEAK-induced cell death". Journal of Immunology. 170 (1): 341–8. doi:10.4049/jimmunol.170.1.341. PMID 12496418.
Tian XL, Kadaba R, You SA, Liu M, Timur AA, Yang L, Chen Q, Szafranski P, Rao S, Wu L, Housman DE, DiCorleto PE, Driscoll DJ, Borrow J, Wang Q (February 2004). "Identification of an angiogenic factor that when mutated causes susceptibility to Klippel-Trenaunay syndrome". Nature. 427 (6975): 640–5. Bibcode:2004Natur.427..640T. doi:10.1038/nature02320. PMC 1618873. PMID 14961121.
Kim SH, Kang YJ, Kim WJ, Woo DK, Lee Y, Kim DI, Park YB, Kwon BS, Park JE, Lee WH (April 2004). "TWEAK can induce pro-inflammatory cytokines and matrix metalloproteinase-9 in macrophages". Circulation Journal. 68 (4): 396–9. doi:10.1253/circj.68.396. PMID 15056843.
Jin L, Nakao A, Nakayama M, Yamaguchi N, Kojima Y, Nakano N, Tsuboi R, Okumura K, Yagita H, Ogawa H (May 2004). "Induction of RANTES by TWEAK/Fn14 interaction in human keratinocytes". The Journal of Investigative Dermatology. 122 (5): 1175–9. doi:10.1111/j.0022-202X.2004.22419.x. PMID 15140220.

Cytokine receptor modulators

Chemokine

See here instead.

CSF

Erythropoietin	Agonists: ARA-290 Asialo erythropoietin Carbamylated erythropoietin CNTO-530 Darbepoetin alfa Epoetin alfa Epoetin beta Epoetin delta Epoetin epsilon Epoetin gamma Epoetin kappa Epoetin omega Epoetin theta Epoetin zeta Erythropoietin (EPO) Erythropoietin-Fc Methoxy polyethylene glycol-epoetin beta (CERA/Mircera) Peginesatide Pegol sihematide (EPO-018B)
G-CSF (CSF3)	Agonists: Filgrastim Granulocyte colony-stimulating factor Lenograstim Leridistim Lipegfilgrastim Nartograstim Pegfilgrastim Pegnartograstim
GM-CSF (CSF2)	Agonists: Ecogramostim Granulocyte macrophage colony-stimulating factor Milodistim Molgramostim Regramostim Sargramostim Antibodies: Mavrilimumab Namilumab Otilimab
M-CSF (CSF1)	Agonists: Cilmostim Interleukin-34 Lanimostim Macrophage colony-stimulating factor Mirimostim Kinase inhibitors: Agerafenib
SCF (c-Kit)	See here instead.
Thrombopoietin	Agonists: Eltrombopag Pegacaristim Promegapoietin Romiplostim Thrombopoietin (THPO, MGDF)

Interferon

IFNAR (α/β, I)	Agonists: Albinterferon Interferon alpha (interferon alfa, IFN-α) Interferon alfa (IFNA1, IFNA2, IFNA4, IFNA5, IFNA6, IFNA7, IFNA8, IFNA10, IFNA13, IFNA14, IFNA16, IFNA17, IFNA21) Interferon alfa 2a Interferon alfa 2b Interferon alfa n1 Interferon alfacon-1 Interferon alpha-n3 Interferon beta (IFN-β) (IFNB1, IFNB3) Interferon beta 1a Interferon beta 1b Interferon kappa (IFN-ε/κ/τ/ζ, IFNK) Interferon omega (IFN-ω, IFNW1) Peginterferon alfa-2a Peginterferon alfa-2b Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept
IFNGR (γ, II)	Agonists: Interferon gamma (IFN-γ) Interferon gamma 1b Antibodies: Emapalumab Fontolizumab
IFNLR (λ, III)	See IL-28R (IFNLR) here instead.

Interleukin

See here instead.

TGFβ

See here instead.

TNF

See here instead.

Others

JAK
(inhibitors)

JAK1	Abrocitinib Baricitinib Filgotinib Momelotinib Oclacitinib Peficitinib Ruxolitinib Tofacitinib (tasocitinib) Upadacitinib
JAK2	Atiprimod AZD-1480 Baricitinib CHZ868 Cucurbitacin I (elatericin B, JSI-124) CYT387 Lestaurtinib NSC-7908 NSC-33994 Pacritinib Peficitinib Ruxolitinib SD-1008 Tofacitinib (tasocitinib)
JAK3	Cercosporamide Decernotinib (VX-509) Peficitinib Ritlecitinib TCS-21311 Tofacitinib (tasocitinib) WHI-P 154 ZM-39923 ZM-449829
TYK2	Deucravacitinib